Objective The patient's clinical features at hemodialysis initiation can affect their prognosis in the subsequent dialysis period; however, these features have not been fully elucidated in very elderly subjects. The purpose of this study was to clarify the clinical characteristics associated with cardiovascular and chronic kidney disease at hemodialysis initiation. Methods Twenty consecutive very elderly patients with end-stage renal disease (ESRD) (! 80 years; VE group) and 35 consecutive control patients with ESRD (<60 years; control group) were included in this study. All patients had started maintenance hemodialysis therapy at our institution. We evaluated the clinical characteristics, laboratory data, thoracic aortic calcification (TAC) and echocardiographic parameters, including aortic valve calcification (AVC), mitral valve calcification and mitral annular calcification (MAC). Results The diastolic blood pressure was significantly lower and pulse pressure values were significantly higher in the VE group than in the control group, whereas the estimated glomerular filtration rate and cardiac function were comparable between the two groups. Despite having lower serum phosphate and calciumphosphate product levels, the VE group exhibited more severe TAC, AVC and MAC than the control group. Furthermore, the duration of hospitalization was significantly shorter in the very elderly patients followed by nephrologists than in those who were not. Conclusion Our findings suggest that atherosclerotic lesions are more severe in very elderly patients at hemodialysis initiation.
Introduction
The number of patients receiving hemodialysis has increased each year worldwide. Furthermore, elderly patients constitute a growing segment of the hemodialysis population (1) . Because clinical practice guidelines for dialysis initiation have traditionally taken an age-neutral strategy, clinicians must sometimes make difficult decisions for such patients. Therefore, some researchers advocate the need for additional clinical guidelines for elderly patients. Elderly patients often have many problems, such as decreased activities of daily living (ADLs), dementia, malnutrition and a reduced cardiopulmonary function. These issues are associated with controversy regarding the appropriateness of initiating dialysis in elderly patients (2) . Some elderly patients may derive substantial benefits from dialysis therapy, whereas others will receive no benefits and may even be harmed. Therefore, it is very important to categorize the characteristics of very elderly (VE) patients with end-stage chronic kidney disease (CKD). However, there have only been a few reports on these topics.
In the present study, we examined the clinical characteristics, including parameters of cardiovascular disease (CVD) and the effects of management by nephrologists, on the duration of hospitalization in VE patients with CKD.
Materials and Methods

Study patients
This was a retrospective study. Twenty consecutive VE patients with end-stage renal disease (ESRD) (! 80 years; VE group) and 35 consecutive control patients with ESRD (<60 years; control group) hospitalized at our institution between January 2008 and December 2012 were enrolled in the present study. None of the subjects rejected hemodialysis initiation during the study period. Patients with acute kidney injury after surgery or as a result of a worsening condition, such as that involving severe infection or cancer, and those with insufficient data were excluded.
In an additional analysis, VE patients with CKD were divided into two groups based on whether they had been followed by nephrologists for at least six months. We compared the clinical features at hemodialysis initiation and the duration of hospitalization between the two groups.
CVD included acute myocardial infarction, angina pectoris, congestive heart failure, valvular disease, arrhythmia and stroke diagnosed by experienced cardiologists and neurologists.
The study protocol was approved by the appropriate institutional review committee and carried out in accordance with the Helsinki Declaration of 1975 as revised in 2000.
Blood sampling and blood pressure measurement
Blood samples were collected from the patients in the supine position after overnight fasting prior to the initiation of dialysis therapy. All laboratory tests were performed using standardized clinical laboratory methods. Blood pressure (BP) was measured by trained personnel using a calibrated mercury sphygmomanometer and appropriately sized cuffs, while maintaining the subject in the supine position and ensuring standardized conditions.
Echocardiographic examinations
Echocardiography was performed on an interdialysis day. Two-dimensional guided M-mode echocardiography was performed to measure the left ventricular wall mass. The left ventricular diastolic and systolic diameters (LVDd/LVDs), as well as the diastolic thickness of the left ventricular posterior wall (LVPWT) and interventricular septum (IVST), were assessed on the M-mode images in the parasternal longitudinal-axis view. The M-mode analysis was performed according to the American Society of Echocardiography guidelines. The left ventricular mass index (LVMI) (g/m 2 ) and relative wall thickness (RWT) were calculated using these parameters (3).
Cardiovascular calcification evaluation
Cardiovascular calcification was evaluated using echocardiography and chest X-rays. We semi-quantitated the severity of vascular calcification (VC) by counting the number of calcified valve cusps in the aortic valves (AVs) and mitral valves (MVs) and determining the presence of mitral annular calcification (MAC) and thoracic aortic calcification (TAC) (for a total score of 0-7).
Statistical analysis
We used the computer software application StatView 5.0 (SAS Institute, Cary, USA) for all statistical analyses. The values are presented as the mean±SD. The significance of differences between the two groups was analyzed using Student's t-test for continuous variables and the χ 2 test for categorical variables. A p value of less than 0.05 was considered to be statistically significant. Table 1 shows the clinical characteristics of the VE and control patients at hemodialysis initiation. The average age in both groups was 83±4 years (VE group) and 48±8 years (control group), respectively. As for the cause of ESRD, the rate of diabetic nephropathy was lower, while that of nephrosclerosis was higher, in the VE group than in the control group. The average diastolic BP was significantly lower and the pulse pressure was significantly higher in the VE group than in the control group. The prevalence of past CVD was significantly higher in the VE group than in the control group. Although the LVMI values tended to be greater in the control group, other echocardiographic parameters did not differ significantly between the two groups ( Table 2) . The number of patients with LV systolic dysfunction and LVH was also similar between the two groups. Although the serum creatinine levels were significantly lower in the VE group, the estimated glomerular filtration rates were comparable between the two groups. In addition, the serum calcium levels and number of patients with TAC, AV calcification (AVC) and MAC were significantly higher, whereas the serum phosphate and calcium-phosphate product levels were significantly lower, in the VE group than in the control group despite similar rates of treatment with phosphate binders and vitamin D. Total calcification score was also greater in the VE group (Table 3) . However, there were no significant differences in the other clinical parameters between the two groups. In the VE group, 12 patients had been followed by a nephrologist [follow up (F) group], while eight had not [non-follow up (NF) group]. As shown in Table 4 , the hemoglobin, hematocrit, total protein and serum albumin levels were significantly higher and the serum phosphate levels were significantly lower in the F group than in the NF group. In addition, all patients had an arteriovenous fistula and the duration of hospitalization was significantly shorter in the F group than in the NF group (F group; 30.2±3.1 days vs. NF group; 61.7±16.2 days, p<0.05, respectively). Even in the control group, the duration of hospitalization was also shorter among the patients followed by a nephrologist [control follow up (C-F) group; 25.0±8.3 days vs. control non-follow up (C-NF) group; 35.4±15.1 days, p<0.05, respectively]. Nevertheless, this effect was greater in the VE group than in the control group. The duration of hospitalization was relatively long because the study population included emergent dialysis patients.
Results
Discussion
In the present study, the renal function and echocar- diographic parameters at dialysis initiation did not differ between the VE and control groups, the degree of vascular and valvular calcification was more severe in the VE group than in the control group and the duration of hospitalization was significantly shorter in the F group than in the NF group.
It is difficult to determine which strategy should be implemented in elderly patients with end-stage disease. In general, elderly patients have various problems, including severe CVD, an impaired cognitive function and decreased ADLs, etc. Therefore, there is a high possibility that clinicians will encounter difficult situations in the clinical setting. It has also been reported that a nonambulatory status and the number of comorbid conditions are associated with very high mortality rates after dialysis initiation (1, 4) . However, the clinical characteristics of VE patients at dialysis initiation are not fully understood. As Kurella et al. previously reported, life expectancy, competing treatment strategies and the patient's preferences are very important factors to consider when making decisions regarding dialysis in elderly patients with ESRD (5). Taking into account these facts, it is essential to recognize the specific characteristics of these patients at dialysis initiation and consider various treatment strategies. Therefore, in the present study, we compared the clinical characteristics of young patients to those of VE patients at hemodialysis initiation. In our institution, all VE patients who did not meet the exclusion criteria were started on hemodialysis therapy.
As for the timing of dialysis initiation, previous studies have reported that early dialysis initiation is associated with lower mortality and a shorter duration of hospitalization (6, 7) . It has also been reported that the renal function in elderly patients at the initiation of hemodialysis therapy increases over time (1) . The annual data report of the United States Renal Data System (USRD) also showed that the average estimated glomerular filtration rate (eGFR) is 12.2 mL/min/1.73 m 2 among patients more than 75 years of age started on hemodialysis therapy (8) . The results of the current study showed no significant differences in the renal function at dialysis initiation between the young and elderly patients. The IDEAL study, a randomized trial of the timing of dialysis initiation, demonstrated that the early initiation of dialysis in ESRD patients does not improve their survival or clinical outcomes, although the average age of the study patients was only 60 years (9) . Hence, early dialysis initiation does not result in morbidity, mortality or quality of life (QOL) benefits unless accompanied by compelling reasons for initiating dialysis treatment (10). As mentioned above, a nonambulatory status and the number of comorbid conditions greatly affect mortality in elderly patients (1, 5) . Therefore, the patient's condition at dialysis initiation appears to greatly influence their prognosis.
In the present study, the hemoglobin levels and parameters associated with chronic kidney disease-mineral bone disorder (CKD-MBD) were well controlled in the patients followed by a nephrologist, and these patients were discharged earlier without serious complications than those followed by a non-nephrologist. Furthermore, all patients followed by a nephrologist already had an arteriovenous shunt when they were admitted to our hospital. These results indicate that these patients were followed carefully and were started on hemodialysis at the appropriate time. Furthermore, it has been reported that late referrals to nephrologists result in worse outcomes than early referrals (11) . In addition, other previous studies have demonstrated that unplanned dialysis initiation is common in older patients with ESRD and is associated with higher mortality (12, 13) . Therefore, if patients and their families choose positive treatment for CKD, it is beneficial to refer them to a nephrologist as soon as possible.
CVD is a leading cause of death in patients with CKD. Patients with LV systolic dysfunction have a significantly higher mortality rate than those with a normal LV function (14) . It is also known that vascular and valvular calcification is associated with CVD morbidity and mortality in patients with CKD (15, 16) . In the present study, although the prevalence of a past history of CVD was significantly greater among the VE patients, the echocardiographic parameters were similar between the control patients and VE patients. In contrast, despite good control of the serum calcium and phosphate levels, vascular and valvular calcification was more severe in the VE patients than in the control patients. Furthermore, diastolic BP was significantly lower and pulse pressure was significantly higher in the VE patients than in control patients. These results reflect the progression of atherosclerotic lesions in VE patients. Therefore, elderly patients are considered to have a high risk of CVD, and clinicians should perform a detailed examination to screen for CVD at hemodialysis initiation.
This study is associated with several limitations. For example, the number of study patients was relatively low. In addition, we did not collect longitudinal data or follow the patients prospectively. However, because it was difficult to collect so many patients who were significantly older and had ESRD at a single institution and few previous papers have reported the characteristics of such patients, we believe that our data are valuable.
Conclusion
The current data suggest that atherosclerotic lesions are more severe in very elderly patients than in younger patients at hemodialysis initiation. Therefore, appropriate management by nephrologists is needed for very elderly patients with ESRD.
The authors state that they have no Conflict of Interest (COI).
